Asthma  >>  roflumilast  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
roflumilast / Generic mfg.
NCT01365533: A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma

Completed
2
48
Canada
Roflumilast, Placebo
AstraZeneca
Allergic Asthma
07/05
07/05
NCT01765192 / 2012-002064-27: Roflumilast Plus Montelukast in Adults With Severe Asthma

Completed
2
64
Europe, RoW
Roflumilast, Daxas, Daliresp, Roflumilast placebo, Montelukast, Singulair, Pluralair
AstraZeneca
Asthma
10/13
10/13
2011-002101-29: Efficacy of Roflumilast in Treatment of Severe Asthma

 
2
30
Europe
roflumilast, BY217, Daxas, Daxas
Nycomed GmbH, Nycomed GmbH
severe uncontrolled asthma
 
01/12
NCT03532490: Trial of Roflumilast in Asthma Management (TRIM)

Completed
2
38
US
Roflumilast 500 Mcg Oral Tablet, Daliresp, Placebo oral capsule
Johns Hopkins University, American Lung Association, National Heart, Lung, and Blood Institute (NHLBI)
Asthma, Obesity
07/21
07/21

Download Options